230 related articles for article (PubMed ID: 15076229)
1. Extracellular nitric oxide release mediates soluble guanylate cyclase-independent vasodilator action of spermine NONOate: comparison with other nitric oxide donors in isolated rat femoral arteries.
Miller MR; Okubo K; Roseberry MJ; Webb DJ; Megson IL
J Cardiovasc Pharmacol; 2004 Mar; 43(3):440-51. PubMed ID: 15076229
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: influence of the mechanism of nitric oxide generation.
Homer KL; Fiore SA; Wanstall JC
J Pharm Pharmacol; 1999 Feb; 51(2):135-9. PubMed ID: 10217311
[TBL] [Abstract][Full Text] [Related]
3. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
4. Cyclic GMP-independent relaxation of rat pulmonary artery by spermine NONOate, a diazeniumdiolate nitric oxide donor.
Homer KL; Wanstall JC
Br J Pharmacol; 2000 Oct; 131(4):673-82. PubMed ID: 11030715
[TBL] [Abstract][Full Text] [Related]
5. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
Jebelovszki E; Kiraly C; Erdei N; Feher A; Pasztor ET; Rutkai I; Forster T; Edes I; Koller A; Bagi Z
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2558-64. PubMed ID: 18408126
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases.
Hussain MB; MacAllister RJ; Hobbs AJ
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1151-9. PubMed ID: 11179059
[TBL] [Abstract][Full Text] [Related]
7. Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion.
Wanstall JC; Jeffery TK; Gambino A; Lovren F; Triggle CR
Br J Pharmacol; 2001 Oct; 134(3):463-72. PubMed ID: 11588100
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cyclic GMP and potassium channels in relaxation evoked by the nitric oxide donor, diethylamine NONOate, in the rat small isolated mesenteric artery.
Sampson LJ; Plane F; Garland CJ
Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):220-5. PubMed ID: 11521164
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
Tseng CM; Tabrizi-Fard MA; Fung HL
J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
[TBL] [Abstract][Full Text] [Related]
10. In vitro comparison of two NONOates (novel nitric oxide donors) on rat pulmonary arteries.
Homer K; Wanstall J
Eur J Pharmacol; 1998 Aug; 356(1):49-57. PubMed ID: 9761423
[TBL] [Abstract][Full Text] [Related]
11. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteries.
Miller MR; Roseberry MJ; Mazzei FA; Butler AR; Webb DJ; Megson IL
Eur J Pharmacol; 2000 Nov; 408(3):335-43. PubMed ID: 11090652
[TBL] [Abstract][Full Text] [Related]
12. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryl trinitrate-tolerant rat femoral arteries.
Miller MR; Megson IL; Roseberry MJ; Mazzei FA; Butler AR; Webb DJ
Eur J Pharmacol; 2000 Sep; 403(1-2):111-9. PubMed ID: 10969151
[TBL] [Abstract][Full Text] [Related]
13. Effects of nitric oxide donors and inhibitors of nitric oxide signalling on endothelin- and serotonin-induced contractions in human placental arteries.
Sand AE; Andersson E; Fried G
Acta Physiol Scand; 2002 Mar; 174(3):217-23. PubMed ID: 11906320
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms that produce nitric oxide-mediated relaxation of cerebral arteries during atherosclerosis.
Didion SP; Heistad DD; Faraci FM
Stroke; 2001 Mar; 32(3):761-6. PubMed ID: 11239199
[TBL] [Abstract][Full Text] [Related]
15. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock.
Zingarelli B; Haskó G; Salzman AL; Szabó C
Crit Care Med; 1999 Sep; 27(9):1701-7. PubMed ID: 10507586
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway.
Antonova GN; Snead CM; Antonov AS; Dimitropoulou C; Venema RC; Catravas JD
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H893-903. PubMed ID: 17012359
[TBL] [Abstract][Full Text] [Related]
17. Glutathione causes coronary vasodilation via a nitric oxide- and soluble guanylate cyclase-dependent mechanism.
Cheung PY; Schulz R
Am J Physiol; 1997 Sep; 273(3 Pt 2):H1231-8. PubMed ID: 9321811
[TBL] [Abstract][Full Text] [Related]
18. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
Onoue H; Katusic ZS
Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
20. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
